Normal RVSP (n = 76) | Elevated RVSP (n = 32) | p-value | |
---|---|---|---|
Age, years, mean ± SD | 44 ± 12.5 | 49 ± 14.8 | NS |
Male sex, n (%) | 48 (64) | 19 (58) | NS |
Race, n (%) | |||
- White | 40 (53) | 18 (55) | NS |
- Asian | 9 (12) | 6 (18) | NS |
- Black | 12 (16) | 2 (6) | NS |
- Other | 14 (19) | 7 (21) | NS |
BMI, kg/m2, mean ± SD | 24.8 ± 5.7 | 23.7 ± 4.9 | NS |
Cause of ESRD, n (%) | |||
- Diabetic nephropathy | 8 (11) | 4 (12) | NS |
- Glomerulonephritis | 29 (39) | 15 (46) | NS |
- Hypertensive nephrosclerosis | 4 (5) | 3 (9) | NS |
- Polycystic kidney disease | 7 (9) | 3 (9) | NS |
- Other | 27 (36) | 8 (24) | NS |
Type of renal replacement therapy prior to intensive hemodialysis, n (%) | |||
- Chronic kidney disease not on dialysis | 23 (31) | 9 (27) | NS |
- Non-intensive hemodialysis | 27 (36) | 12 (36) | NS |
- Peritoneal dialysis | 5 (7) | 6 (18) | NS |
- Renal transplantation | 20 (27) | 6 (18) | NS |
Initial access type, n (%) | |||
- CVC | 40 (53) | 15 (46) | NS |
- AVF | 26 (35) | 17 (52) | NS |
- AVG | 9 (12) | 1 (3) | NS |
Duration of ESKD, years, median (IQR) | 1.7 (0.3–12) | 2.6 (0.2–14) | NS |
Hours of dialysis per week, mean ± SD | 36 ± 8.0 | 34 ± 7.8 | NS |
Total follow up in years, mean ± SD | 3.9 ± 2.2 | 4.1 ± 2.3 | NS |
Time between echocardiograms in years, mean ± SD | 3.2 ± 2.8 | 3.4 ± 2.2 | NS |
Co-existing medical conditions, n (%) | |||
- Diabetes | 17 (23) | 10 (30) | NS |
- Smoking history | 12 (16) | 8 (24) | NS |
- Hypertension | 65 (87) | 28 (85) | NS |
- Coronary artery disease | 5 (7) | 5 (15) | NS |
- Peripheral vascular disease | 2 (3) | 4 (12) | 0.04 |
- Stroke | 2 (3) | 4 (12) | 0.04 |
Baseline blood pressure therapy | |||
- Number of antihypertensives, mean ± SD | 1.9 ± 1.3 | 1.5 ± 1.2 | NS |
1-Year blood pressure therapy | |||
- Number of antihypertensives, mean ± SD | 0.8 ± 1.0 | 0.8 ± 0.9 | NS |